{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
Enabling breakthrough medicines achieve the outcomes they were designed for. We unlock the full therapeutic potential of innovative drug candidates through our next-gen nanomedicine delivery platform. We want to establish our biovectors as the universal standard for targeted therapeutic delivery.
Stallergenes Greer is a fully integrated global healthcare company specialising in the research, diagnosis and treatment of allergies through the development and commercialisation of allergen immunotherapy (AIT) products and services.
RC TRITEC is an established company offering custom synthesis of tritium-labeled compounds, a range of tritiated catalog products, storage service and disposal of radiochemicals. We have over 60 years of experience in the safe handling of tritium gas using in-house developed high-vacuum equipment.
AVEctivate supports pharma, biotech and diagnostic companies aiming to make a positive difference to patients, and health care providers by offering strategic consulting, project management and interim management. Believing that change is the only constant, we embrace the future as an opportunity.
Juvion develops advanced therapeutics aimed at preserving neuron-muscle connectivity, tackling immobility and sarcopenia to extend healthspan.
Enzene is a fully integrated CIDMO with sites in Pune (India) & New Jersey (USA), offering discovery to commercial supply. Its EnzeneX™ FCCM™ tech leads next-gen biologics, aiming to cut mAb costs below $40/g by 2025. Learn more at www.enzene.com.
We are offering worldwide professional medical writing and related services to the pharmaceutical (human & veterinary), biotech, medical device and other industries, CROs and academic institutions. With over 20 years of experience in the field, we guarantee the best possible medical writing.
Chelonia collaborates with industry, academia, and public institutions to accelerate R&D, commercialize innovations, and secure funding. We offer strategic partnerships, expert guidance, and project support to maximize impact.
Complyomics supports Life Sciences companies in core areas as: Build and maintain robust Quality Systems in compliance with regulatory requirements. Provide externalized QA. Audits Develop expertise in Bioanalytical / Analytical areas Identify / assess / supervise sub-contractors Due diligence
We are managing a portfolio of biotech opportunities, each selected based on promising science and potential for addressing unmet medical needs. Our team of industry-leading experts has extensive development & biotech experience which we put into practice to accelerate science into care.
Alpha Lyncis SA is a Swiss-based service provider supporting implementation and transfer of biotechnological and chemical production processes. We complement our customers teams to develop holistic solutions for manufacturing challenges and accelerate the success of highly regulated products.
At Stämm we develop accessible, plug & play biomanufacture solutions; allowing an automatized, continuous and more efficient production of biologics and cell therapies while managing media conditions. We have reinvented biomanufacturing by providing an alternative to the known biomass production.
Solvias is a Contract Research, Development & Manufacturing Organization We offer comprehensive, high quality and fast, complex small molecule API early phase development and GMP-manufacturing by ensuring the interplay of scientifically outstanding experts in every required individual discipline.
Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines. Our manufacturing site for oral vaccines is located in Thörishaus, 15 km southwest of Bern.
Altorfer Engineering is a specialized contractor and consulting company. We provide expertise in engineering and project management services, and technology transfers. Our focus is on developing and managing aseptic formulation and fill-finish processes tailored to your receiving sites.
Olgram develops new drugs to cure immune deficiencies for which there are no satisfactory therapeutic solutions. Our 1st clinical application is immunodepression post traumatic brain injury, affecting 5 million people. We also develop new anti-infectious to cure the chronic bacterial infection.
Caland SA provides a professional, confidential, competitive and impeccable service of pharma-grade CO2 extraction, distillation and cannabis formulation based on GMP requirements. A modern production line, coupled to a qualified ERP, ensures uncompromising quality of all products and services.
MRGN Advisors was established in 2015 to advise CEOs, boards and investors on portfolio strategy, commercial and market access development, partnering and investment advisory in pharma, biologicals, vaccines, med tech and healthcare IT. Our motto: Even monkeys fall from trees — Japanese Proverb
Our goal is to deliver innovations in health care through cutting-edge tech and research, addressing challenges in antimicrobial therapies to improve patient outcomes. We are committed to delivering superior treatments that promote healing and improve quality of life globally.
KBI Biopharma is a global biologics CDMO providing development and manufacturing. With best-in-class technology and solutions, KBI empowers its industry from discovery to commercialization. KBI works closely with each of its 500+ client partners thanks to its eight locations in Europe and the USA.
Xlife Sciences is a publicly listed life sciences incubator and accelerator. Xlife is focused on the value development and commercialization of promising research projects from universities and other research institutions. The goal is to bridge research and development to healthcare markets.
Lucerna Chem is one of the leading distributors for life science products in Switzerland, providing high quality reagents and kits from more than 70 suppliers for both research and diagnostics. We conveniently supply our customers with a variety of 4 Mio. products in simple domestic shipments.
Immune response on a chip!
ten23 health, headquartered in Basel, Switzerland, was founded in 2021. We are the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups: we develop, manufacture, and test tomorrow’s medicines.
ZETA is an end-to-end solution provider and innovation leader for pharma & biotech and specializes in the design, automation, and qualification of customer-specific systems for pharmaceutical manufacturing. ZETA is an EPCMv contractor, drives digtialization and develops decarbonization strategies.
Novochizol SA researches and develops applications of Novochizol, a unique chitosan nanoparticle technology that yields different carriers of small molecules, peptides, nucleic acids and proteins for sustained, localized delivery to any living tissue, with intracellular targeting potential.
Pharma-Consulting ENABLE GmbH provides support to biopharmaceutical companies (small & large) in product development and manufacturing covering early to late stage clinical and commercial operations. Pharma-Consulting ENABLE is active worldwide and has been created by Alain Pralong in 2008.
A Swiss microbiota biotherapeutics and mucosal vaccines company with two technology platforms: ApyraVax for the generation of innovative mucosal vaccines; ApyraMed with indications in IBD, dysbiosis induced by antibiotic treatments and unhealthy diet, and as enhancer in cancer immunotherapy.
Cancer Research and Biotechnology AG (CRB) is a Swiss biopharma company developing a novel small molecule treatments effective in pancreatic c., triple-negative breast c., and colon cancer. CRB091 is non-toxic, targeting triple-negative breast cancer (TNBC). First in-human submission in 2025.
We provide our clients, however complex their challenges may be, with effective and high quality solutions throughout the life cycle of their products and the evolution of their company.
Regen Lab is a global leader in products for autologous regenerative medicine based on freshly prepared platelet rich plasma from the patient’s own blood, used either alone or combination with hyaluronic acid or other fresh autologous cells from the patient’s fat or bone marrow.
Microsphere (MS) is a CDMO focused on new developments, cGMP manufacturing, R&D, analytical and regulatory support. MS is able to address complex challenges, including formulations for poorly water-soluble drugs, considering the extensive expertise in Spray Drying and Capsule Filling.
Catalent is the global leader in enabling pharma, cell & gene therapy and biopharma partners to optimize product development, launch, and full life-cycle supply for patients around the world. Catalent helps accelerate over 1,000 partner programs every year for partners of all sizes.
The Swiss based Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides. As a full service provider Bachem offers products for research, clinical development and commercial applications.
Kuhner AG is a leading developer and manufacturer of shaking machines, single use bioreactors, automation and online measuring technology for the international market. Furthermore, Kuhner sales lab-equipment (freeze dryers, centrifuges, etc.) to the Swiss market.
THE CULTURED HUB works with a global network of start-ups to find answers to the food industry’s most pressing questions in order to define the food of the future. We are a scale up as a service company for industrial biotech, accelerating the development of sustainable foods through biotech.
ASTRA Therapeutics is a drug design and development company located at the Swiss Innovation Park Innovaare, Villigen. We harness atomic resolution comparative structural data to design novel small molecule drugs to treat serious diseases caused by eukaryotic pathogens with unmet medical needs.
We are focusing on worldwide sourcing,distributing and custom manufacturing of fine chemicals, intermediates, ingredients, specialities, niche APIs and NCE’S since 1997.
For small and medium size Biotech and Pharmaceutical business and its service providers, Marvapharm offers commercial consultancy services and an international network, in order to develop its business, acquire or provide pharmaceutical products and services, gastroenterologic, vaccines, antibiotic
Expertise in exploratory clinical drug/diagnostic development is available across a number of disease areas. Timing of input into the developmental strategy from regulatory and commercial perspectives is important in moving development programs towards success.
Maintenance-free cell culture analyzer technology, BioProfile FLEX2. With autosampling from ambr® 15 and 250 cell culture systems, FLEX2 provides key chemistries and gases, cell density, viability, and osmolality with single sample and data output stream.
MEMS's are semi-allergens recognizing the chemically modified and polymerized sequences of proteins that accumulate in aging and infection. The protein rubbish occludes the membrane's receptors and causes cell degeneration and autoimmunity. MEMS’s lead to the elimination of waste-stopping pathology
scienceindustries, the Swiss Business Association Chemistry Pharma Life Sciences, supports some 250 member companies: fostering an innovation-friendly environment, creating a competitive production and business framework, enabling attractive market conditions, and facilitating global market access.
Herbonis is specialized in products of herbal origin containing active components and in finding feed ingredient solutions for animal nutrition. Herbonis was acquired by Innovad in 2023.
Cell Culture Technologies is an independent and privately funded Swiss biotech company specialised in the development and application of in vitro cell culture for the production of cells and biotherapeutics in fully synthetic, chemically defined culture environments.
The group, offering state-of-the-art regenerative medicine solutions, has developed a technology platform that gave birth to therapies aiming at tissue regeneration across different applications, in order to provide pertinent and sustainable solutions leveraging the human's natural endowment.